Copyright
©The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Jul 14, 2018; 24(26): 2902-2914
Published online Jul 14, 2018. doi: 10.3748/wjg.v24.i26.2902
Published online Jul 14, 2018. doi: 10.3748/wjg.v24.i26.2902
Role of band ligation for secondary prophylaxis of variceal bleeding
Ioanna Aggeletopoulou, Christos Konstantakis, Christos Triantos, Department of Gastroenterology, University Hospital of Patras, Patras 26504, Greece
Spilios Manolakopoulos, 2nd Department of Internal Medicine, Hippokration General Hospital of Athens, Athens 11527, Greece
Author contributions: Aggeletopoulou I and Konstantakis C were responsible for the literature review and analysis; Aggeletopoulou I, Manolakopoulos S and Triantos C were responsible for drafting the manuscript and interpretation of the data; Manolakopoulos S and Triantos C were responsible for revision of the manuscript for important intellectual content; all authors issued final approval for the version to be submitted.
Conflict-of-interest statement: Spilios Manolakopoulos has received research grants from Gilead Sciences, Regulus and Bristol-Myers Squibb and fees for lectures and advisory board from Gilead Sciences, Roche, Bristol-Myers Squibb, GSK, AbbVie and MSD; Christos Triantos has received fees as a speaker/advisory board member and research/travel grants from MSD, Roche, AbbVie, Janssen, Bristol-Myers Squibb, Bayer and Gilead Sciences.
PRISMA 2009 Checklist statement: The authors read the PRISMA 2009 Checklist, and the manuscript was prepared and revised according to the PRISMA 2009 Checklist.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Christos Triantos, PhD, Assistant Professor in Internal Medicine and Gastroenterology, Department of Gastroenterology, University Hospital of Patras, D. Stamatopoulou 4, Rio, Patras 26504, Greece. chtriantos@hotmail.com
Telephone: +30-69-72894651 Fax: +30-26-10625382
Received: March 29, 2018
Peer-review started: March 30, 2018
First decision: May 17, 2018
Revised: June 5, 2018
Accepted: June 25, 2018
Article in press: June 25, 2018
Published online: July 14, 2018
Processing time: 106 Days and 10.3 Hours
Peer-review started: March 30, 2018
First decision: May 17, 2018
Revised: June 5, 2018
Accepted: June 25, 2018
Article in press: June 25, 2018
Published online: July 14, 2018
Processing time: 106 Days and 10.3 Hours
Core Tip
Core tip: Variceal bleeding is a life-threatening complication of liver cirrhosis. The current guidelines recommend the use of band ligation together with β-blockers in the setting of secondary prophylaxis for variceal bleeding in patients with cirrhosis. This review summarizes data from meta-analyses and randomized trials to demonstrate the most recent advances in the management of variceal rebleeding. The current evidence suggests that the efficacy of band ligation is increased by adding β-blockers in accordance with the current guidelines. However, combination therapy does not procure a survival advantage. Innovative interventions and more effective novel strategies aiming to improve clinical outcomes should be developed.